Skip to main content
Reimbursement strategy

Market Access Strategy for Medical Devices in Europe

Strategic recommendations on the topic of market access pathways for medical devices and IVD tests

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

2026 campaign for CHOP and SwissDRG system changes open in Switzerland

On June 1, 2026, the application window opened for changes to the Swiss Classification of Surgical Procedures (CHOP). Interested parties may submit applications until September 14, 2026. Applications for changes to coding rules may be submitted until July 13, 2026.

On the same day, the application window also opened for changes to the SwissDRG system. Interested parties may submit applications until July 13, 2026. The results of DRG applications submitted in 2026 will be reflected in the 2028 version of SwissDRG.

Applications for both processes may be submitted by the Medical Professional Association (FMH), the Conference of the Cantonal Ministers of Public Health (GDK/CDS), the Swiss Association of Hospitals (H+), health insurance companies and their associations, and the Medical Tariff Commission (MTK/CTM).

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.